Literature DB >> 21507376

Placental expression of angiogenic factors in Trisomy 13.

Michelle Silasi1, Sarosh Rana, Camille Powe, Bruce Cohen, Kee-Hak Lim, Zsuzsanna K Zsengellér, S Ananth Karumanchi, Isaac E Stillman.   

Abstract

OBJECTIVE: Increased levels of soluble fms-like tyrosine kinase (sFlt-1) in Trisomy 13 pregnancies are thought to be mediated by the placenta. This study aimed to compare sFlt-1 expression in Trisomy 13 (n = 7) placentas with that in control placentas (Trisomy 21, n = 11, and euploid, n = 6). STUDY
DESIGN: This was a retrospective case-control study analyzing paraffin-embedded placental blocks that were stained with hematoxylin and eosin and antibodies to sFlt-1. Their staining intensity was compared using a semiquantitative technique. The Kruskal-Wallis test and Wilcox rank sum test were used for statistical analysis.
RESULTS: The median staining was significantly higher in Trisomy 13 compared with control specimens (P = .008) (for Trisomy 13 vs Trisomy 21, P = .003, and Trisomy 13 vs euploid, P = .004).
CONCLUSION: Our study demonstrates that Trisomy 13 placentas express more sFlt-1 than control placentas. These results strengthen the hypothesis that the increased incidence of preeclampsia in Trisomy 13 pregnancies is secondary to placental up-regulation of sFlt-1.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507376     DOI: 10.1016/j.ajog.2011.02.027

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  Placental transcriptomes in the common aneuploidies reveal critical regions on the trisomic chromosomes and genome-wide effects.

Authors:  Katherine Bianco; Matthew Gormley; Jason Farrell; Yan Zhou; Oliver Oliverio; Hannah Tilden; Michael McMaster; Susan J Fisher
Journal:  Prenat Diagn       Date:  2016-07-25       Impact factor: 3.050

Review 2.  The etiology of preeclampsia.

Authors:  Eunjung Jung; Roberto Romero; Lami Yeo; Nardhy Gomez-Lopez; Piya Chaemsaithong; Adithep Jaovisidha; Francesca Gotsch; Offer Erez
Journal:  Am J Obstet Gynecol       Date:  2022-02       Impact factor: 8.661

Review 3.  New developments in the pathogenesis of preeclampsia.

Authors:  Mihran V Naljayan; S Ananth Karumanchi
Journal:  Adv Chronic Kidney Dis       Date:  2013-05       Impact factor: 3.620

4.  Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia.

Authors:  Augustine Rajakumar; Ana Sofia Cerdeira; Sarosh Rana; Zsuzsanna Zsengeller; Lia Edmunds; Arun Jeyabalan; Carl A Hubel; Isaac E Stillman; Samir M Parikh; S Ananth Karumanchi
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

5.  Trisomy 13-confined placental mosaicism: is there an increased risk of gestational hypertensive disorders?

Authors:  Sarah K Dotters-Katz; Emily Hardisty; Erin Campbell; Neeta Vora
Journal:  Prenat Diagn       Date:  2017-07-25       Impact factor: 3.050

Review 6.  Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders.

Authors:  Sarosh Rana; Suzanne D Burke; S Ananth Karumanchi
Journal:  Am J Obstet Gynecol       Date:  2020-10-20       Impact factor: 8.661

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.